GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL) » Definitions » E10

PharmaLundensis AB (XSAT:PHAL) E10 : kr-0.26 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is PharmaLundensis AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PharmaLundensis AB's adjusted earnings per share data for the three months ended in Mar. 2024 was kr-0.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-0.26 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 1.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of PharmaLundensis AB was 1.20% per year. The lowest was -1.20% per year. And the median was 0.00% per year.

As of today (2024-06-11), PharmaLundensis AB's current stock price is kr0.64. PharmaLundensis AB's E10 for the quarter that ended in Mar. 2024 was kr-0.26. PharmaLundensis AB's Shiller PE Ratio of today is .


PharmaLundensis AB E10 Historical Data

The historical data trend for PharmaLundensis AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaLundensis AB E10 Chart

PharmaLundensis AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.28 -0.28 -0.28 -0.29 -0.27

PharmaLundensis AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.28 -0.27 -0.27 -0.27 -0.26

Competitive Comparison of PharmaLundensis AB's E10

For the Biotechnology subindustry, PharmaLundensis AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaLundensis AB's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaLundensis AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PharmaLundensis AB's Shiller PE Ratio falls into.



PharmaLundensis AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PharmaLundensis AB's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.03/132.2054*132.2054
=-0.030

Current CPI (Mar. 2024) = 132.2054.

PharmaLundensis AB Quarterly Data

per share eps CPI Adj_EPS
201406 -0.095 100.432 -0.125
201409 -0.069 100.161 -0.091
201412 -0.058 100.225 -0.077
201503 -0.034 99.950 -0.045
201506 -0.043 99.995 -0.057
201509 -0.060 100.228 -0.079
201512 -0.052 100.276 -0.069
201603 -0.026 100.751 -0.034
201606 -0.069 101.019 -0.090
201609 -0.052 101.138 -0.068
201612 -0.043 102.022 -0.056
201703 -0.052 102.022 -0.067
201706 -0.069 102.752 -0.089
201709 -0.060 103.279 -0.077
201712 -0.314 103.793 -0.400
201803 -0.052 103.962 -0.066
201806 -0.079 104.875 -0.100
201809 -0.044 105.679 -0.055
201812 -0.052 105.912 -0.065
201903 -0.044 105.886 -0.055
201906 -0.070 106.742 -0.087
201909 -0.044 107.214 -0.054
201912 -0.055 107.766 -0.067
202003 -0.026 106.563 -0.032
202006 -0.035 107.498 -0.043
202009 -0.088 107.635 -0.108
202012 -0.097 108.296 -0.118
202103 -0.018 108.360 -0.022
202106 -0.026 108.928 -0.032
202109 -0.018 110.338 -0.022
202112 -0.018 112.486 -0.021
202203 -0.044 114.825 -0.051
202206 -0.018 118.384 -0.020
202209 -0.018 122.296 -0.019
202212 -0.030 126.365 -0.031
202303 -0.020 127.042 -0.021
202306 -0.027 129.407 -0.028
202309 -0.027 130.224 -0.027
202312 -0.036 131.912 -0.036
202403 -0.030 132.205 -0.030

Add all the adjusted EPS together and divide 10 will get our e10.


PharmaLundensis AB  (XSAT:PHAL) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


PharmaLundensis AB E10 Related Terms

Thank you for viewing the detailed overview of PharmaLundensis AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaLundensis AB (XSAT:PHAL) Business Description

Traded in Other Exchanges
N/A
Address
Medicon Village, Scheelevagen 2, Lund, SWE, 22381
PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.

PharmaLundensis AB (XSAT:PHAL) Headlines

No Headlines